273 related articles for article (PubMed ID: 19637874)
1. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
Li Z; Zhou ZL; Miao ZH; Lin LP; Feng HJ; Tong LJ; Ding J; Li YC
J Med Chem; 2009 Aug; 52(16):5115-23. PubMed ID: 19637874
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and anticancer activity evaluation of novel C14 heterocycle substituted epi-triptolide.
Xu H; Tang H; Feng H; Li Y
Eur J Med Chem; 2014 Feb; 73():46-55. PubMed ID: 24378709
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel triptolide analogues for anticancer activity.
Zhou B; Miao Z; Deng G; Ding J; Yang Y; Feng H; Li Y
Bioorg Med Chem Lett; 2010 Nov; 20(21):6217-21. PubMed ID: 20833543
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.
Xu F; Shi X; Li S; Cui J; Lu Z; Jin Y; Lin Y; Pang J; Pan J
Bioorg Med Chem; 2010 Mar; 18(5):1806-15. PubMed ID: 20149665
[TBL] [Abstract][Full Text] [Related]
5. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of novel D-ring-modified triptolide analogues: structure-cytotoxic activity relationship studies on the D-ring of triptolide.
Zhou B; Li X; Tang H; Miao Z; Feng H; Li Y
Org Biomol Chem; 2011 May; 9(9):3176-9. PubMed ID: 21409265
[TBL] [Abstract][Full Text] [Related]
7. Semisynthesis of triptolide analogues: effect of γ-lactone and C-14 substituents on cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2011 May; 21(10):3046-9. PubMed ID: 21470864
[TBL] [Abstract][Full Text] [Related]
8. Semisynthesis of C-ring modified triptolide analogues and their cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2006 Apr; 16(7):1947-9. PubMed ID: 16455242
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
Xu H; Tang H; Feng H; Li Y
ChemMedChem; 2014 Feb; 9(2):290-5. PubMed ID: 24339424
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity of some new eriocalyxin B derivatives.
Zhao Y; Niu XM; Qian LP; Liu ZY; Zhao QS; Sun HD
Eur J Med Chem; 2007 Apr; 42(4):494-502. PubMed ID: 17189663
[TBL] [Abstract][Full Text] [Related]
11. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.
Nanduri S; Nyavanandi VK; Thunuguntla SS; Kasu S; Pallerla MK; Ram PS; Rajagopal S; Kumar RA; Ramanujam R; Babu JM; Vyas K; Devi AS; Reddy GO; Akella V
Bioorg Med Chem Lett; 2004 Sep; 14(18):4711-7. PubMed ID: 15324893
[TBL] [Abstract][Full Text] [Related]
14. Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes.
Xiong Y; Wang K; Pan Y; Sun H; Tu J
Bioorg Med Chem Lett; 2006 Feb; 16(4):786-9. PubMed ID: 16309905
[TBL] [Abstract][Full Text] [Related]
15. LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo.
Xu H; Fan X; Zhang G; Liu X; Li Z; Li Y; Jiang B
Biomed Pharmacother; 2017 Sep; 93():1004-1009. PubMed ID: 28724258
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
Ikeda T; Yaegashi T; Matsuzaki T; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Jan; 21(1):342-5. PubMed ID: 21126872
[TBL] [Abstract][Full Text] [Related]
17. New lupane derived compounds with pro-apoptotic activity in cancer cells: synthesis and structure-activity relationships.
Sarek J; Klinot J; Dzubák P; Klinotová E; Nosková V; Krecek V; Korínková G; Thomson JO; Janost'áková A; Wang S; Parsons S; Fischer PM; Zhelev NZ; Hajdúch M
J Med Chem; 2003 Dec; 46(25):5402-15. PubMed ID: 14640549
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents.
Reddy MV; Mallireddigari MR; Cosenza SC; Pallela VR; Iqbal NM; Robell KA; Kang AD; Reddy EP
J Med Chem; 2008 Jan; 51(1):86-100. PubMed ID: 18088089
[TBL] [Abstract][Full Text] [Related]
19. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs.
Roy S; Hagen KD; Maheswari PU; Lutz M; Spek AL; Reedijk J; van Wezel GP
ChemMedChem; 2008 Sep; 3(9):1427-34. PubMed ID: 18537202
[TBL] [Abstract][Full Text] [Related]
20. Semisynthesis of triptolide analogues: effect of B-ring substituents on cytotoxic activities.
Xu H; Chen Y; Tang H; Feng H; Li Y
Bioorg Med Chem Lett; 2014 Dec; 24(24):5671-5674. PubMed ID: 25467158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]